|
Mutation Information
|
Mutation Site
|
M204V |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Combined Mutation
|
rt.L180M+rt.M204V |
|
Genotype/Subtype
|
B;C |
|
Relevant Drug
|
lamivudine (LAM);entecavir (ETV);adefovir (ADV);telbivudine (LDT) |
|
Country
|
China |
Literature Information
|
PubMed PMID
|
29654894
|
|
Disease
|
HBV infection
|
|
Published Year
|
2018 |
|
Journal
|
International journal of antimicrobial agents |
|
Title
|
Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009-2016: A retrospective study. |
|
Author
|
Guo X,Wu J,Wei F,Ouyang Y,Li Q,Liu K,Wang Y,Zhang Y,Chen D |
|
Evidence
|
Moreover, A181T/V, ETV resistance mutations and multidrug resistance mutations were found more frequently in HBV genotype C compared with genotype B (21.2% vs. 8.5%, 12.4% vs. 7.9% and 5.9% vs. 3.0%, respectively), whereas M204I and N236T were more predominant in genotype B than genotype C (40.3% vs. 20.8% and 11.3% vs. 1.8%, respectively).
|
|
|
HBV Mutation Detail Information